Skip to content

Title 10 — Armed Forces

Part I · Chapter 7 — Boards, Councils, and Committees

§ 176. Armed Forces Institute of Pathology

Statutory text

(a)
(1)

There is in the Department of Defense an Institute to be known as the Armed Forces Institute of Pathology (hereinafter in this section referred to as the “Institute”), which has the responsibilities, functions, authority, and relationships set forth in this section. The Institute shall be a joint entity of the three military departments, subject to the authority, direction, and control of the Secretary of Defense.

(2)

The Institute shall consist of a Board of Governors, a Director, two Deputy Directors, and a staff of such professional, technical, and clerical personnel as may be required.

(3)

The Board of Governors shall consist of the Assistant Secretary of Defense for Health Affairs, who shall serve as chairman of the Board of Governors, the Assistant Secretary of Health and Human Services for Health, the Surgeons General of the Army, Navy, and Air Force, the Under Secretary for Health of the Department of Veterans Affairs, and a former Director of the Institute, as designated by the Secretary of Defense, or the designee of any of the foregoing.

(4)

The Director and the Deputy Directors shall be appointed by the Secretary of Defense.

(b)
(1)

In carrying out the provisions of this section, the Institute is authorized to—

(A)

contract with the American Registry of Pathology (established under section 177 of this title) for cooperative enterprises in medical research, consultation, and education between the Institute and the civilian medical profession under such conditions as may be agreed upon between the Board of Governors and the American Registry of Pathology;

(B)

make available at no cost to the American Registry of Pathology such space, facilities, equipment, and support services within the Institute as the Board of Governors deems necessary for the accomplishment of their mutual cooperative enterprises; and

(C)

contract with the American Registry of Pathology for the services of such professional, technical, or clerical personnel as are necessary to fulfill their cooperative enterprises.

(2)

No contract may be entered into under paragraph (1) which obligates the Institute to make outlays in advance of the enactment of budget authority for such outlays.

(c)

The Director is authorized, with the approval of the Board of Governors, to enter into agreements with the American Registry of Pathology for the services at any time of not more than six distinguished pathologists or scientists of demonstrated ability and experience for the purpose of enhancing the activities of the Institute in education, consultation, and research. Such pathologists or scientists may be appointed by the Director to administrative positions within the components or subcomponents of the Institute and may be authorized by the Director to exercise any or all professional duties within the Institute, notwithstanding any other provision of law. The Secretary of Defense, on a case-by-case basis, may waive the limitation on the number of distinguished pathologists or scientists with whom agreements may be entered into under this subsection if the Secretary determines that such waiver is in the best interest of the Department of Defense.

(d)

The Secretary of Defense shall promulgate such regulations as may be necessary to prescribe the organization, functions, and responsibilities of the Institute.

Legislative history

Reconstructed from this section’s Code source credit and amendment notes, resolved against the local Statutes at Large. Editorial notes are evidence, not the law that made the change.

  1. Department of Defense Appropriation Authorization Act, 1977

    Pub. L. 94–361 title VIII § 811(b) · 90 Stat. 923

    Enacted · 10 U.S.C. § 176

    Added Pub. L. 94–361, title VIII, § 811(b), July 14, 1976, 90 Stat. 933

    Source evidence

    Code source credit
    Added Pub. L. 94–361, title VIII, § 811(b), July 14, 1976, 90 Stat. 933

    Enacted provision · exact public law section
    (b) Chapter 7 of title 10, United States Code, is amended by adding at the end thereof the following new sections: “§ 176. Armed Forces Institute of Pathology “(a) (1) There is in the Department of Defense an Institute to be known as the Armed Forces Institute of Pathology (hereinafter in this section referred to as the ‘Institute’), which has the responsibilities, functions, authority, and relationships set forth in this section. The Institute shall be a joint entity of the three military departments, subject to the authority, direction, and control of the Secretary of Defense. “(2) The Institute shall consist of a Board of Governors, a Director, two Deputy Directors, and a staff of such professional, technical, and clerical personnel as may be required. “(3) The Board of Governors shall consist of the Assistant Secretary of Defense for Health Affairs, who shall serve as chairman of the Board of Governors, the Assistant Secretary of Health, Education, and Welfare for Health, the Surgeons General of the Army, Navy’, and Air Force, the Chief Medical Director of the Veterans’ Administration, and a former Director of the Institute, as designated by the Secretary7 of Defense, or the designee of any of the foregoing. “(4) The Director and the Deputy Directors shall be appointed by the Secretary of Defense. “(b) (1) In carrying out the provisions of this section, the Institute is authorized to— “(A) contract with the American Registry of Pathology’ (established under section 177) for cooperative enterprises in medical research, consultation, and education between the Institute and the civilian medical profession under such conditions as may be agreed upon between the Board of Governors and the American Registry of Pathology; “(B) make available at no cost, to the American Registry of Pathology such space, facilities, equipment, and support services within the Institute as the Board of Governors deems necessary for the accomplishment of their mutual cooperative enterprises; and “(C) contract with the American Registry of Pathology for the services of such professional, technical, or clerical personnel as are necessary to fulfill their cooperative enterprises. “(2) No contract may be entered into under paragraph (1) which obligates the Institute to make outlays in advance of the enactment of budget authority for such outlays. “(c) The Director is authorized, with the approval of the Board of Governors, to enter into agreements with the American Registry of Pathology for the services at any time of not more than six distinguished pathologists or scientists of demonstrated ability and experience for the purpose of enhancing the activities of the Institute in education, consultation, and research. Such pathologists or scientists may be appointed by the Director to administrative positions within the components or subcomponents of the Institute and may be authorized by the Director to exercise any or all professional duties within the Institute, notwithstanding any other provision of law. “(d) The Secretary of Defense shall promulgate such regulations as may be necessary to prescribe the organization, functions, and responsibilities of the Institute. “§ 177. American Registry of Pathology “(a) (1) There is authorized to be established a nonprofit corporation to be known as the American Registry of Pathology which shall not for any purpose be an agency or establishment of the United States Government, The American Registry of Pathology shall be subject to the provisions of this section and, to the extent not inconsistent with this section, to the District of Columbia Nonprofit Corporation Act (D.C. Code, sec. 29–1001 et seq.). “(2) The American Registry of Pathology’ shall have a Board of Board of Members. Members (hereinafter in this section referred to as the ‘Board’) consisting of not less than eleven individuals who are representatives of those professional societies and organizations which sponsor individual registries of pathology at the Armed Fences Institute of Pathology, of whom one shall be elected annually by the Board to serve as chairman. Each such sponsor shall appoint one member to the Board for a term of four years. “(3) The American Registry of Pathology shall have a Director, who shall be appointed by the Board with the concurrence of the Director of the Armed Forces Institute of Pathology, and such other officers as may be named and appointed by the Board. Such officers shall be compensated at rates fixed by the Board and shall serve at the pleasure of the Board. “(4) The members of the initial Board shall serve as incorporators and shall take whatever actions are necessary to establish under the District of Columbia Nonprofit Corporation Act the corporation authorized by paragraph (1). “(5) The term of office of each member of the Board shall be four Term. years, except that (A) any member appointed to fill a vacancy occurring prior to the expiration of the term for which his predecessor was appointed shall be appointed for the remainder of such term, (B) the terms of office of members first taking office shall begin on the date of incorporation and shall expire, as designated at the time of their appointment and to the maximum extent practicable, one fourth at the end of one year, one fourth at the end of two years, one fourth at the end of three years, and one fourth at the end of four years, and (C) a member whose term has expired may serve until his successor has qualified. No member shall be eligible to serve more than two consecutive terms of four years each. “(6) Any vacancy in the Board shall not affect its powers, but such vacancy shall be filled in the manner in which the original appointment was made. “(b) In order to carry out the purposes of this section, the American Functions. Registry of Pathology is authorized to— “(1) enter into contracts with the Armed Forces Institute of Pathology for the provision of such services and personnel as may be necessary to carry out their cooperative enterprises; “(2) enter into contracts with public and private organizations for the writing, editing, printing, and publishing of fascicles of tumor pathology, atlases, and other material; “(3) accept gifts and grants from and enter into contracts with individuals, private foundations, professional societies, institutions, and governmental agencies; “(4) enter into agreements with professional societies for the establishment and maintenance of Registries of Pathology; and “(5) serve as a focus for the interchange between military and civilian pathology and encourage the participation of medical, dental, and veterinary sciences in pathology for the mutual benefit, of military and civilian medicine. “(c) In the performance of the functions set forth in subsection (b), the American Registry of Pathology is authorized to— “(1) enter into such other contracts, leases, cooperative agreements, or other transactions as the Board deems appropriate to conduct the activities of the American Registry of Pathology; and “(2) charge such fees for professional services as the Board deems reasonable and appropriate. “(d) The American Registry of Pathology may transmit to the Director and the Board of Governors of the Armed Forces Institute of Pathology and to the sponsors referred to in subsection (a) (2) annually, and at such other times as it deems desirable, a comprehensive and detailed report of its operations, activities, and accomplishments.”.

  2. Defense Officer Personnel Management Act

    Pub. L. 96–513 § 511(6)(A) · 94 Stat. 2835

    Substituted · 10 U.S.C. § 176(a)(3)

    Pub. L. 96–513, § 511(6)(A), substituted “Secretary of Health and Human Services” for “Secretary of Health, Education, and Welfare”

    Source evidence

    Code amendment note
    Subsec. (a)(3). Pub. L. 96–513, § 511(6)(A), substituted “Secretary of Health and Human Services” for “Secretary of Health, Education, and Welfare”.

    Enacted provision · exact public law section
    (A) in subsection (a)(3), by striking out “Secretary of Health, Education, and Welfare” and inserting in lieu thereof “Secretary of Health and Human Services”; and

    Effective date note
    Amendment by Pub. L. 96–513 effective Dec. 12, 1980, see section 701(b)(3) of Pub. L. 96–513, set out as a note under section 101 of this title.

  3. Defense Officer Personnel Management Act

    Pub. L. 96–513 § 511(6)(B) · 94 Stat. 2835

    Inserted · 10 U.S.C. § 176(b)(1)(A)

    Pub. L. 96–513, § 511(6)(B), inserted “of this title” after “177”

    Source evidence

    Code amendment note
    Subsec. (b)(1)(A). Pub. L. 96–513, § 511(6)(B), inserted “of this title” after “177”.

    Enacted provision · exact public law section
    (B) in subsection (b)(1)(A), by inserting “of this title” after “section 177”.

    Effective date note
    Amendment by Pub. L. 96–513 effective Dec. 12, 1980, see section 701(b)(3) of Pub. L. 96–513, set out as a note under section 101 of this title.

  4. National Defense Authorization Act for Fiscal Years 1990 and 1991

    Pub. L. 101–189 div. A title XVI § 1621(a)(1) · 103 Stat. 1352

    Substituted · 10 U.S.C. § 176(a)(3)

    Pub. L. 101–189 substituted “Department of Veterans Affairs” for “Veterans’ Administration”

    Source evidence

    Code amendment note
    Subsec. (a)(3). Pub. L. 101–189 substituted “Department of Veterans Affairs” for “Veterans’ Administration”.

    Enacted provision · exact public law section
    (1) The following sections are amended by striking out “Veterans’ Administration” and inserting in lieu thereof “Department of Veterans Affairs”: sections 176(a)(3), 772(g), 1174(h)(2), 1201(3)(B), 1203(4)(A), 1203(4)(B), 1203(4)(C), 1204(4)(B), 1206(4), 1209, 1210(c), 1210(d), 1210(e), 1212(c), 1218(a)(1), 1431(b)(1), 1433 (in two places), 1441, 1449, 1450(h), 1452(g)(1), 1452(g)(5), 1476(b), 2641(a), 2641(b)(1) (in two places), 2641(d)(2), 4342(a)(1), 4621(d), 4683(a)(1), 4713(c), 6954(a)(1), 7603, 9342(a)(1), 9621(d), and 9713(c).

  5. Pub. L. 103–160 div. A title VII § 733 · 107 Stat. 1547

    Inserted · 10 U.S.C. § 176(c)

    Pub. L. 103–160 inserted at end “The Secretary of Defense, on a case-by-case basis, may waive the limitation on the number of distinguished pathologists or scientists with whom agreements may be entered into under this subsection if the Secretary determines that such waiver is in the best interest of the Department of Defense.”

    Source evidence

    Code amendment note
    Subsec. (c). Pub. L. 103–160 inserted at end “The Secretary of Defense, on a case-by-case basis, may waive the limitation on the number of distinguished pathologists or scientists with whom agreements may be entered into under this subsection if the Secretary determines that such waiver is in the best interest of the Department of Defense.”

    Enacted provision · exact public law section
    SEC. 733. AUTHORITY FOR THE ARMED FORCES INSTITUTE OF PATHOLOGY TO OBTAIN ADDITIONAL DISTINGUISHED PATHOLOGISTS AND SCIENTISTS. Section 176(c) of title 10, United States Code, is amended by adding at the end the following new sentence: “The Secretary of Defense, on a case-by-case basis, may waive the limitation on the number of distinguished pathologists or scientists with whom agreements may be entered into under this subsection if the Secretary determines that such waiver is in the best interest of the Department of Defense.”.

  6. National Defense Authorization Act for Fiscal Year 1996

    Pub. L. 104–106 § 903(a) · 110 Stat. 186

    Repealed · 10 U.S.C. § 176(a)(3)

    Pub. L. 104–106, § 903(a), (f)(1), which directed amendment of subsec. (a)(3), eff. Jan. 31, 1997, by substituting “official in the Department of Defense with principal responsibility for health affairs” for “Assistant Secretary of Defense for Health Affairs” and “Under Secretary for Health of the Department of Veterans Affairs” for “Chief Medical Director of the Department of Veterans Affairs”, was repealed by Pub. L. 104–201

    Source evidence

    Code amendment note
    Subsec. (a)(3). Pub. L. 104–106, § 903(a), (f)(1), which directed amendment of subsec. (a)(3), eff. Jan. 31, 1997, by substituting “official in the Department of Defense with principal responsibility for health affairs” for “Assistant Secretary of Defense for Health Affairs” and “Under Secretary for Health of the Department of Veterans Affairs” for “Chief Medical Director of the Department of Veterans Affairs”, was repealed by Pub. L. 104–201.

    Enacted provision · exact public law section
    (a) Effective Date.— The amendments 10 USC 131 note. made by this section 10 USC 131 note, shall take effect on January 31, 1997.

  7. National Defense Authorization Act for Fiscal Year 2002

    Pub. L. 107–107 div. A title X § 1048(a)(4) · 115 Stat. 1012

    Substituted · 10 U.S.C. § 176(a)(3)

    Pub. L. 107–107 substituted “Under Secretary for Health” for “Chief Medical Director”

    Source evidence

    Code amendment note
    Subsec. (a)(3). Pub. L. 107–107 substituted “Under Secretary for Health” for “Chief Medical Director”.

    Enacted provision · exact public law section
    (4) Section 176(a)(3) is amended by striking “Chief Medical Director” and inserting “Under Secretary for Health”.

7 of 7 references resolved to an enrolled provision

Editorial Notes

Amendments1980–2001 · 5 rounds

2001

Subsec. (a)(3). Pub. L. 107–107 substituted “Under Secretary for Health” for “Chief Medical Director”.

1996

Subsec. (a)(3). Pub. L. 104–106, § 903(a), (f)(1), which directed amendment of subsec. (a)(3), eff. , by substituting “official in the Department of Defense with principal responsibility for health affairs” for “Assistant Secretary of Defense for Health Affairs” and “Under Secretary for Health of the Department of Veterans Affairs” for “Chief Medical Director of the Department of Veterans Affairs”, was repealed by Pub. L. 104–201.

1993

Subsec. (c). Pub. L. 103–160 inserted at end “The Secretary of Defense, on a case-by-case basis, may waive the limitation on the number of distinguished pathologists or scientists with whom agreements may be entered into under this subsection if the Secretary determines that such waiver is in the best interest of the Department of Defense.”

1989

Subsec. (a)(3). Pub. L. 101–189 substituted “Department of Veterans Affairs” for “Veterans’ Administration”.

1980

Subsec. (a)(3). Pub. L. 96–513, § 511(6)(A), substituted “Secretary of Health and Human Services” for “Secretary of Health, Education, and Welfare”.

Subsec. (b)(1)(A). Pub. L. 96–513, § 511(6)(B), inserted “of this title” after “177”.

Statutory Notes and Related Subsidiaries

Effective Date of 1980 Amendment

Amendment by Pub. L. 96–513 effective , see section 701(b)(3) of Pub. L. 96–513, set out as a note under section 101 of this title.

Establishment of Joint Pathology Center

Pub. L. 110–181, div. A, title VII, § 722, , 122 Stat. 199, provided that:

“(a)

Findings.—

Congress makes the following findings:

“(1)

The Secretary of Defense proposed to disestablish all elements of the Armed Forces Institute of Pathology, except the National Medical Museum and the Tissue Repository, as part of the recommendations of the Secretary for the closure of Walter Reed Army Medical Center in the 2005 round of defense base closure and realignment.

“(2)

The Defense Base Closure and Realignment Commission altered, but did not reject, the proposal of the Secretary of Defense to disestablish the Armed Forces Institute of Pathology.

“(3)

The Commission’s recommendation that the Armed Forces Institute of Pathology’s ‘capabilities not specified in this recommendation will be absorbed into other DOD, Federal, or civilian facilities’ provides the flexibility to retain a Joint Pathology Center as a Department of Defense or Federal entity.

“(b)

Sense of Congress.—

It is the sense of Congress that the Armed Forces Institute of Pathology has provided important medical benefits to the Armed Forces and to the United States and that the Federal Government should retain a Joint Pathology Center.

“(c)

Establishment.—

“(1)

Establishment required.—

The President shall establish and maintain a Joint Pathology Center that shall function as the reference center in pathology for the Federal Government.

“(2)

Establishment within dod.—

Except as provided in paragraph (3), the Joint Pathology Center shall be established in the Department of Defense, consistent with the final recommendations of the 2005 Defense Base Closure and Realignment Commission, as approved by the President.

“(3)

Establishment in another department.—

If the President makes a determination, within 180 days after the date of the enactment of this Act [], that the Joint Pathology Center cannot be established in the Department of Defense, the Joint Pathology Center shall be established as an element of a Federal agency other than the Department of Defense. The President shall incorporate the selection of such agency into the determination made under this paragraph.

“(d)

Services.—

The Joint Pathology Center shall provide, at a minimum, the following:

“(1)

Diagnostic pathology consultation services in medicine, dentistry, and veterinary sciences.

“(2)

Pathology education, to include graduate medical education, including residency and fellowship programs, and continuing medical education.

“(3)

Diagnostic pathology research.

“(4)

Maintenance and continued modernization of the Tissue Repository and, as appropriate, utilization of the Repository in conducting the activities described in paragraphs (1) through (3).”

National Museum of Health and Medicine

Pub. L. 103–337, div. A, title X, § 1067, , 108 Stat. 2851, as amended by Pub. L. 105–78, title VII, § 702, , 111 Stat. 1524, provided that:

“(a)

Purpose.—

It is the purpose of this section—

“(1)

to display and interpret the collections of the Armed Forces Institute of Pathology currently located at Walter Reed Medical Center; and

“(2)

to designate the public facility of the Armed Forces Institute of Pathology as the National Museum of Health and Medicine.

“(b)

Designation.—

The public facility of the Armed Forces Institute of Pathology shall also be known as the National Museum of Health and Medicine.”

Congressional Findings and Declaration

Pub. L. 94–361, title VIII, § 811(a), , 90 Stat. 933, provided that:

“(1)

The Congress hereby finds and declares that—

“(A)

the Armed Forces Institute of Pathology offers unique pathologic support to national and international medicine;

“(B)

the Institute contains the Nation’s most comprehensive collection of pathologic specimens for study and a staff of prestigious pathologists engaged in consultation, education, and research;

“(C)

the activities of the Institute are of unique and vital importance in support of the health care of the Armed Forces of the United States;

“(D)

the activities of the Institute are also of unique and vital importance in support of the civilian health care system of the United States;

“(E)

the Institute provides an important focus for the exchange of information between civilian and military medicine, to the benefit of both; and

“(F)

it is important to the health of the American people and of the members of the Armed Forces of the United States that the Institute continue its activities in serving both the military and civilian sectors in education, consultation, and research in the medical, dental, and veterinary sciences.

“(2)

The Congress further finds and declares that beneficial cooperative efforts between private individuals, professional societies, and other entities on the one hand and the Armed Forces Institute of Pathology on the other can be carried out most effectively through the establishment of a private corporation.”

Credits

1976–2001 · 7 acts
  1. 1976Added Pub. L. 94–361, title VIII, § 811(b), , 90 Stat. 933
  2. 1980amended Pub. L. 96–513, title V, § 511(6), , 94 Stat. 2920
  3. 1989Pub. L. 101–189, div. A, title XVI, § 1621(a)(1), , 103 Stat. 1602
  4. 1993Pub. L. 103–160, div. A, title VII, § 733, , 107 Stat. 1697
  5. 1996Pub. L. 104–106, div. A, title IX, § 903(f)(1), , 110 Stat. 402
  6. 1996Pub. L. 104–201, div. A, title IX, § 901, , 110 Stat. 2617
  7. 2001Pub. L. 107–107, div. A, title X, § 1048(a)(4), , 115 Stat. 1222.
Show as published

(Added Pub. L. 94–361, title VIII, § 811(b), , 90 Stat. 933; amended Pub. L. 96–513, title V, § 511(6), , 94 Stat. 2920; Pub. L. 101–189, div. A, title XVI, § 1621(a)(1), , 103 Stat. 1602; Pub. L. 103–160, div. A, title VII, § 733, , 107 Stat. 1697; Pub. L. 104–106, div. A, title IX, § 903(f)(1), , 110 Stat. 402; Pub. L. 104–201, div. A, title IX, § 901, , 110 Stat. 2617; Pub. L. 107–107, div. A, title X, § 1048(a)(4), , 115 Stat. 1222.)

Parsed from the official OLRC USLM XML in data/usc_all/usc10.xml · release point 119-108 · OLRC build 2026-04-17

USLM identifier /us/usc/t10/s176